Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion type Assertion NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_head.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion description "[Blockade of either CXCL5 or CXCR2 may be a critical adjunct antiangiogenic therapy against pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_provenance.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion evidence source_evidence_literature NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_provenance.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion SIO_000772 21356384 NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_provenance.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion wasDerivedFrom befree-20140225 NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_provenance.
- NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_assertion wasGeneratedBy ECO_0000203 NP261176.RA2HpCMunVkCtodLxsYDwYYhvF8i8_2HydVIbTcoIbZZQ130_provenance.